Dr. Huppert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
Fl 3
San Francisco, CA 94143Phone+1 415-353-7070Fax+1 415-502-1976
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 2018
Harvard Medical SchoolClass of 2015
Certifications & Licensure
CA State Medical License 2017 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Implantation of engineered adipocytes suppresses tumor progression in cancer models.Hai P Nguyen, Kelly An, Yusuke Ito, Bhushan N Kharbikar, Rory Sheng
Nature Biotechnology. 2025-02-04 - Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers.Alejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, Christina Yau, Michal Marczyk
Clinical Cancer Research. 2025-01-17 - 6 citationsDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo
Nature Medicine. 2024-12-01
Press Mentions
UCSF Cancer Specialists to Present Clinical Findings at Major ConferenceJune 2nd, 2022- Adding Immunotherapy to Neoadjuvant Chemo Boosts pCR in HR-Positive Breast CancerDecember 9th, 2023
- No Benefit to Adjuvant-Only Immunotherapy in Early TNBCDecember 9th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
